Journal of the Chemical Society. Chemical communications p. 817 - 819 (1992)
Update date:2022-08-04
Topics:
Baker, Raymond
Showell, Graham A.
Street, Leslie J.
Saunders, John
Hoogsteen, Karst
et al.
The cyclopropyloxadiazole derivative described in the title has been shown to be a functionally selective M1 partial agonist with antagonist properties in M2 and M3 muscarinic receptor assays; conformational studies indicate free rotation around the oxadiazole-azanorbornane bond, whilst X-ray studies reveal that the cyclopropyl group is in conjugation with the oxadiazole C=N bond.
View MoreShijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
WUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Doi:10.1016/S0040-4020(01)91911-8
(1983)Doi:10.1002/(sici)1521-3773(19990215)38:4<516::aid-anie516>3.0.co;2-b
(1999)Doi:10.1016/0040-4020(95)98694-D
(1995)Doi:10.1002/ejoc.200500058
(2005)Doi:10.1021/jm901559e
(2010)Doi:10.1016/j.tetlet.2005.07.075
(2005)
